FRAZIER LIFE SCIENCES MANAGEMENT, LP
FRAZIER LIFE SCIENCES MANAGEMENT, LP is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US and Europe investing in healthcare-tech.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- healthcare-tech
- Invests in
- US-wide, Europe
- Founded
- 2021
- Assets under management
- $6.9B
Check size not disclosed
Thesis
Frazier Life Sciences Management is an investment firm focused on investing in and building biopharmaceutical companies that are developing and commercializing novel therapeutics in the global healthcare sector. The firm employs venture capital and public equity strategies, investing across all stages, from company formation to public companies, with a focus on early-stage private biopharmaceutical companies, with an emphasis on company creation and Series A investments. The firm primarily invests in North America and Europe. As of December 31, 2025, Frazier Life Sciences Management has $6,966,857,739 in AUM. The firm raised $1300000000 for its 12th fund, its largest to date. The previous venture fund raised $987 million.
Common questions
Does FRAZIER LIFE SCIENCES MANAGEMENT, LP invest at the Pre-seed stage?
Yes. FRAZIER LIFE SCIENCES MANAGEMENT, LP lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does FRAZIER LIFE SCIENCES MANAGEMENT, LP invest?
FRAZIER LIFE SCIENCES MANAGEMENT, LP invests in the US and Europe.